1. O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials. (6th August 2021) Authors: Taylor, H; Donnez, J; Petraglia, F; Gemzell Danielsson, K; Renner, S; Bestel, E; Gotteland, J P; Humberstone, A; Garner, E Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗